[Federal Register Volume 91, Number 75 (Monday, April 20, 2026)]
[Notices]
[Pages 21009-21010]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-07581]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on June 24th, 2026. The topic for this 
meeting will be ``Innovative Research Partnerships in Diabetic Retinal 
Disease: Insights and Opportunities.'' The meeting is open to the 
public.

DATES: The meeting will be held on June 24, 2026, from 12:00 p.m. to 
3:00 p.m. EDT.

ADDRESSES: This meeting will held via the Teams online video 
conferencing platform. For details, and to register, please go to the 
virtual event's page: https://events.gcc.teams.microsoft.com/event/1ea07235-9153-4af6-9982-d4818eadbdb3@14b77578-9773-42d5-8507-251ca2dc2b06.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, including a draft agenda, which will be posted when 
available, see the DMICC website, https://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/diabetes-mellitus-interagency-coordinating-committee-dmicc?dkrd=lgdmn0022, or contact Dr. William 
Cefalu, Executive Secretary of the Diabetes Mellitus Interagency 
Coordinating Committee, National Institute of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Boulevard, Democracy 2, Room 6037, 
Bethesda, MD 20892, telephone: 301-435-1011; email: [email protected].

SUPPLEMENTARY INFORMATION: In accordance with 42 U.S.C.285c-3, the 
DMICC, chaired by the National Institute of Diabetes and Digestive and 
Kidney Diseases (NIDDK) and comprising members of the Department of 
Health and Human Services and other federal agencies that support 
diabetes-related activities, facilitates cooperation, communication, 
and collaboration on diabetes among government entities. DMICC 
meetings, held several times a year, provide an opportunity for 
Committee members to learn about and discuss current and future 
diabetes programs in DMICC member organizations and to identify 
opportunities for collaboration. The June 24, 2026, DMICC meeting will 
focus on ``Innovative Research Partnerships in Diabetic Retinal 
Disease: Insights and Opportunities.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 5 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the

[[Page 21010]]

meeting, oral comments will be allowed on a first-come, first-serve 
basis.
    Members of the public who would like to receive email notifications 
about future DMICC meetings should register for the listserv when 
registering on the meeting's event page: https://events.gcc.teams.microsoft.com/event/1ea07235-9153-4af6-9982-d4818eadbdb3@14b77578-9773-42d5-8507-251ca2dc2b06.

    Dated: April 15, 2026.
William T. Cefalu,
Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, 
National Institute of Diabetes and Digestive and Kidney Diseases, 
National Institutes of Health.
[FR Doc. 2026-07581 Filed 4-17-26; 8:45 am]
BILLING CODE 4167-05-P